Back to Search Start Over

Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report

Authors :
Si‐Man Huang
Tao Tao
Chao‐Ling Wan
Tian‐Mei Wu
Han‐Yu Cao
Yan Qiu
Xiang‐Dong Shen
Bin‐Ru Wang
Shuai‐Shuai Ge
Yan‐Yan Li
Tong‐Tong Zhang
Bing Wu
Sheng‐Li Xue
Source :
Clinical Case Reports, Vol 11, Iss 1, Pp n/a-n/a (2023)
Publication Year :
2023
Publisher :
Wiley, 2023.

Abstract

Abstract Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and venetoclax, which could provide corresponding treatment ideas for clinical practice.

Details

Language :
English
ISSN :
20500904
Volume :
11
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Clinical Case Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.773244ff8842be89b88a44e8235d72
Document Type :
article
Full Text :
https://doi.org/10.1002/ccr3.6688